AB124. Mucolipidosis type II: clinical features and laboratories
Part 4: Oral/poster

AB124. Mucolipidosis type II: clinical features and laboratories

Ngoc Thi Bich Can1, Dung Chi Vu1, Thao Phuong Bui1, Khanh Ngoc Nguyen1, Wuh-Liang Hwu2

1Department of Endocrinology, Metabolism and Genetics, Vietnam National Hospital of Paediatrics, Hanoi, Vietnam; 2Department of Medical Genetics, National Taiwan University Hospital, Taiwan


Background: I-cell disease (Mucolipidosis II) is a rare lysosomal storage disorder caused by the deficiency of N-acetylglucosamine-l-phosphotransferase, an enzyme that transfers phosphate groups onto oligosaccharide units of lysosomal enzyme precursors. Due to the absence of transferase activity, the common phosphomannose recognition marker of acid hydrolases is not generated, and the enzymes are not targeted to the lysosomes I. As a consequence the enzymes are secreted into the extracellular space, and high activities can be found in the serum, cerebrospinal fluid and urine of the patients, whereas inside the cells (fibroblasts) the enzyme levels are considerably reduced. Mucolipidosis is also known as I-cell disease because of the coarse granular cytoplasmic inclusions seen in cultured skin fibroblasts which are large lysosomes containing heterogeneous material.

Objective: To describe clinical features and enzyme activity of patients with mucolipidosis type II.

Methods: Clinical features, laboratory and plasma lysosom enzyme activity by four MU-Fluorometric assay was study.

Results and conclusions: Sixteen cases (seven girls and nine boys) onset at 5.93±4.28 years of age the onset age of 2.3±3.1 years (median 1.25) with the feature of joint stiffness and bone deformation. 100% cases admitted with the feature of joint stiffness, chest deformation and kyphoscoliosis, 93.3% coarse facial features. No patients had hepatosplenomegaly on ultrasound, 5/15 patients had heart valves disease. Enzyme assay showed α-Hexosaminidase of 1,885.98±338.7 nmoL/mg plasma/17 h, α-Iduronate sulfatase of 4,534.78±1,062.97 nmoL/mg plasma/4 h. Mucolipidosis has seriously affected the life of the patients.

Keywords: Mucolipidosis type II; I-cell disease


Cite this abstract as: Can NT, Vu DC, Bui TP, Nguyen KN, Hwu WL. Mucolipidosis type II: clinical features and laboratories. Ann Transl Med 2015;3(S2):AB124. doi: 10.3978/j.issn.2305-5839.2015.AB124

Article Options

Download Citation